Bleeding risk after native and transplant kidney biopsy – a single-centre observational study
Open Access
- 5 June 2025
- journal article
- research article
- Published by SMW Supporting Association in Swiss Medical Weekly
- Vol. 155 (6) , 4409
Abstract
STUDY AIM: Renal biopsies provide important and decisive information for diagnosis and therapy. Although biopsies are considered safe, bleeding complications remain a concern. We analysed the complication rate after kidney biopsies in native and transplant kidneys and their association with platelet function analyser bleeding time (PFA BT) and estimated glomerular filtration rate (eGFR). METHODS: This single-centre observational study included all patients who underwent an ultrasound-guided kidney biopsy at the University Hospital Basel from 2015 to August 2019. The main objective was to investigate the association of PFA BT with significant bleeding complications in kidney biopsies. Significant bleeding was defined as a haemoglobin decrease of >10 g/l within 48 hours or the need for transfusion after bleeding, according to the discretion of the treating physician. The pre-biopsy assessment included bleeding time using PFA BT, INR, thrombocyte count, and eGFR. RESULTS: A total of 819 kidney biopsies—285 native and 534 transplant—were analysed. Complications occurred in 32 biopsies (3.9%): 18 (6.3%) in native and 14 (2.6%) in transplant kidneys. Bleeding was the most frequent complication in both groups. Overall, low eGFR (p = 0.01) and prolonged PFA BT (p = 0.02) were associated with bleeding complications. In native kidney biopsies, inpatient biopsy was associated with bleeding complications (p = 0.005), while in transplant kidney biopsies, bleeding complications were associated with time after transplantation (p <0.001), prolonged PFA BT (p <0.001), and diagnostic biopsies (p = 0.01). In the multivariable model, low eGFR was the only significant factor associated with bleeding complications (odds ratio 3.57, 95% confidence interval 1.76-7.23, p <0.001). CONCLUSIONS: A low eGFR, especially below 30 ml/min, is associated with increased bleeding risk in native and transplant kidney biopsies.Keywords
This publication has 22 references indexed in Scilit:
- The risks associated with percutaneous native kidney biopsies: a prospective studyNephrology Dialysis Transplantation, 2022
- Bleeding Complications After Percutaneous Native Kidney Biopsy: Results From the Boston Kidney Biopsy CohortKidney International Reports, 2020
- Comparison of native and transplant kidney biopsies: diagnostic yield and complicationsClinical Kidney Journal, 2018
- A retrospective analysis of complication and adequacy rates of ultrasound-guided native and transplant non-focal renal biopsiesAbdominal Radiology, 2017
- Risk Factors for Severe Bleeding Complications in Percutaneous Renal BiopsyThe American Journal of the Medical Sciences, 2017
- Complications of Ultrasound-Guided Renal Transplant BiopsiesAmerican Journal of Transplantation, 2016
- Bleeding Complications of Native Kidney Biopsy: A Systematic Review and Meta-analysisAmerican Journal of Kidney Diseases, 2012
- Use of the Platelet Function Analyzer to minimize bleeding complications after renal biopsyThrombosis Research, 2009
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication ratesTransplantation, 2003